ArticleHeliyon2023

Design expert software assisted development and evaluation of empagliflozin and sitagliptin combination tablet with improved in-vivo anti-diabetic activities.

Md Saddam Hossain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.